Beijing Wanger Biotechnology Co., Ltd. is a technology company specializing in food safety research and development. The company integrates researching, manufacturing, marketing and servicing, and it is the industrialization base of many national scientific programs and projects in China. The company was set up in 2002 and is headquartered in Beijing, CN.

Guizhou Qinbang Food Safety Science and Technology Co., Ltd., established on 2012-08-17, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(research and development,Production and sales of food safety rapid testing products and related instruments,Food safety testing products and related instruments,6840Clinical laboratory analysis instruments and diagnostic reagents(Contains diagnostic reagents)(Involved in approval,Licensed to operate),Technical extension services;Import and export,Agent import and export,Technology Import and Export(Except for goods and technologies restricted or prohibited by the country);Sales:car(branch office only),chemical reagent(Operate within the scope and period approved by the business license),Instrumentation,laboratory equipment,electronic product(Except for special items),Mechanical equipment and accessories,Wujinjiaodian,Electronic equipment(Except for special items),bags;Realtor;Laboratory intelligent system engineering design;Building decoration project,Mechanical and electrical equipment installation engineering,Design and construction of purification engineering and ventilation environmental protection engineering.)

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

MIBR is developing treatments and vaccines for rare diseases, autoimmune diseases, infectious diseases, cancers, etc. novel drug development using artificial intelligence pursuing the goals of developing new drugs and improving public health on a global scale

Furen Medicines Group is engaged in pharmaceutical research and development, manufacturing and marketing generic drugs.

IDEC Pharmaceuticals develop therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Idec Pharmaceuticals was founded in 1986 by UC-San Diego physician and immunologist Ivor Royston, San Diego bioentrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller. In 2003, Idec Pharmaceuticals was merged with Biogen.

Zhaoke Pharmaceutical (Guangzhou) Ltd., a subsidiary of Lee's Pharmaceutical Holdings Ltd., is a company headquartered in Guangzhou, China, that manufactures and sells pharmaceutical products.

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.

Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA.

Nanjing Maison Biotechnology Co., Ltd., established on 2015-03-24, Business scope includes licensed projects:Import and export;Animal Clinic(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Pet Food and Supplies Wholesale;Feed Additive Sales;Animal Husbandry and Fishery Feed Sales;Feed Raw Material Sales;Bio-feed R&D(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) Limited to branch operations:feed production;Feed additive production

Cervel Neurotech, Inc. (formerly NeoStim, Inc.) located in San Mateo, CA is a privately held medical device company that is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation. Cervel’s technology is a form of repetitive transcranial magnetic stimulation (rTMS) which uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. The company was founded in 2008 by M. Bret Schneider, MD, and David J. Mishelevich, MD, PhD, and entrepreneur Michael J. Partsch, using technology licensed from Stanford Univesity. Acquired by Rio Grande Neurosciences in 2015

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.

Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.

Brainsway's patented breakthrough technology launches a new era in brain disorder treatment. A non-invasive, yet highly effective solution, Brainsway can make a difference in the wellbeing and health of millions of patients worldwide. Brainsway's technology releases millions of patients from a bleak cycle of insufficiently effective treatments and unpleasant side effects. Brainsway's treatment was approved by the FDA for Major Depressive Disorder patients*. The technology is also safe, with no systemic effects or long-term side effects, and highly convenient, requiring only brief daily sessions over a couple of weeks. Brainsway's technology has already been applied in thousands of cases worldwide in the framework of clinical studies. It has also been enthusiastically embraced by leading research institutions worldwide, with over 60 clinical trials performed. Brainsway technology is based on a patent registered by the U.S. National Institutes of Health (NIH). Brainsway is dedicated to research and continuously explores treatments for a variety of brain disorders.

Guangdong Zhugeliang Animal Pharmaceutical Co., Ltd., established on 2000-07-11, Business scope includes agricultural scientific research and experimental development;Animal Husbandry Scientific Research Services;Biomedical Technology Research;Medical technology research and development;Pharmaceutical Research Services;Health Sciences Program Research,to develop;Food Science and Technology Research Services;Agricultural Technology Development Services;Agricultural Technology Consulting,communication service;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Import and export(Excluding franchised products);Technology Import and Export;Commodity wholesale trade(Except for licensed and approved products);Internet Merchandise Sales(Except for licensed and approved products);Sales of biological diagnostic reagents and kits(Does not include license approval items);Sales of Biological Products(Does not include licensed operations);drug development;feed wholesale;Feed Additives Wholesale;feed retail;Feed Additives Retail;Sanitary materials and medical supplies manufacturing;Biopharmaceutical Manufacturing;Manufacturing of Veterinary Drugs;Chinese patent medicine production;Production of Chinese herbal extracts(The specific business items are subject to the drug production license);Chinese herbal medicine processing;Manufacturing of chemical preparations;Disinfectant manufacturing;Chemicals,Biological product(Contains vaccine)wholesale;Biological product(No vaccine)wholesale;Chinese herbal medicine wholesale;Drug retail;Veterinary Drug Sales;feed processing;feed production(Specific product varieties are subject to the feed production license);Aquatic Feed Manufacturing;grain milling;Feed additives,Additive premix feed production;Production of ready-mix powder

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.